MetLife, Inc. $MET Stock Position Decreased by Hantz Financial Services Inc.

Hantz Financial Services Inc. cut its position in MetLife, Inc. (NYSE:MET – Free Report) by 4.7% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 142,044 shares of the financial services provider’s stock after selling 7,036 shares during the quarter. Hantz Financial Services Inc.’s holdings in MetLife were worth $13,375,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. CX Institutional boosted its holdings in MetLife by 1.3% during the third quarter. CX Institutional now owns 8,672 shares of the financial services provider’s stock valued at $817,000 after acquiring an additional 115 shares during the period. Investment Research Partners LLC grew its position in shares of MetLife by 3.9% in the third quarter. Investment Research Partners LLC now owns 3,103 shares of the financial services provider’s stock valued at $292,000 after purchasing an additional 116 shares during the last quarter. McGlone Suttner Wealth Management Inc. increased its stake in shares of MetLife by 0.6% in the third quarter. McGlone Suttner Wealth Management Inc. now owns 22,391 shares of the financial services provider’s stock worth $2,108,000 after purchasing an additional 124 shares during the period. International Private Wealth Advisors LLC increased its stake in shares of MetLife by 3.1% in the third quarter. International Private Wealth Advisors LLC now owns 4,223 shares of the financial services provider’s stock worth $398,000 after purchasing an additional 126 shares during the period. Finally, Capital Analysts LLC lifted its position in shares of MetLife by 0.3% during the 2nd quarter. Capital Analysts LLC now owns 38,262 shares of the financial services provider’s stock worth $3,238,000 after purchasing an additional 129 shares during the last quarter. 94.99% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, CEO Michel Khalaf sold 187,425 shares of the stock in a transaction on Tuesday, November 10th. The shares were sold at an average price of $102.97, for a total value of $19,299,152.25. Following the completion of the transaction, the chief executive officer owned 759,013 shares in the company, valued at approximately $78,155,568.61. This represents a 19.80% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.40% of the company’s stock.

MetLife Stock Performance

MET opened at $102.67 on Monday. The stock has a market cap of $64.52 billion, a PE ratio of 13.39, a P/E/G ratio of 0.97 and a beta of 0.79. The company has a current ratio of 0.21, a quick ratio of 0.21 and a debt-to-equity ratio of 0.65. MetLife, Inc. has a 1 year low of $67.33 and a 1 year high of $106.72. The stock’s 50 day simple moving average is $98.75 and its 200-day simple moving average is $86.90.

MetLife (NYSE:MET – Get Free Report) last issued its earnings results on Wednesday, November 4th. The financial services provider reported $2.78 EPS for the quarter, topping the consensus estimate of $2.77 by $0.01. The firm had revenue of $20.52 billion during the quarter, compared to analysts’ expectations of $19.86 billion. MetLife had a return on equity of 25.71% and a net margin of 6.21%. MetLife’s quarterly revenue was up 18.2% compared to the same quarter last year. During the same period last year, the business earned $2.34 earnings per share. Sell-side analysts forecast that MetLife, Inc. will post 9.91 EPS for the current year.

MetLife declared that its board has initiated a stock buyback program on Wednesday, August 5th that allows the company to repurchase $3 billion in outstanding shares. This repurchase authorization allows the financial services provider to repurchase up to 4.8% of its shares through open market purchases. Share repurchase programs are typically an indication that the company’s management believes its stock is undervalued.

MetLife Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 8th. Shareholders of record on Tuesday, November 3rd will be issued a $0.5925 dividend. This represents a $2.37 annualized dividend and a yield of 2.3%. The ex-dividend date of this dividend is Tuesday, November 3rd. MetLife’s payout ratio is 30.90%.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on MET. Barclays increased their target price on MetLife from $97.00 to $111.00 and gave the company an “overweight” rating in a research note on Wednesday, October 7th. Keefe, Bruyette & Woods lifted their price target on MetLife from $105.00 to $108.00 and gave the stock an “outperform” rating in a research report on Tuesday, August 11th. Evercore reiterated a “mixed” rating on shares of MetLife in a report on Monday, August 24th. Jefferies Financial Group increased their price objective on MetLife from $103.00 to $115.00 and gave the company a “buy” rating in a research report on Monday, August 10th. Finally, Weiss Ratings raised MetLife from a “buy (b)” rating to a “buy (b+)” rating in a research report on Monday, November 9th. Fourteen investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $107.12.

Read Our Latest Report on MET

Key Headlines Impacting MetLife

These are some of the MET headlines that stood out recently:

  • Positive Sentiment: Analysts raised their price targets. Mizuho lifted its target to $117 from $112 and maintained an “outperform” rating; Wells Fargo raised its target to $113 from $110 and kept an “overweight” rating. The higher targets indicate continued analyst confidence and potential upside. Mizuho price target article Wells Fargo price target article
  • Neutral Sentiment: MetLife earned workplace recognition. The company was named among the 2026 Fortune World’s Best Workplaces and topped U.S.-based financial services and insurance companies on the list. This may support its reputation as an employer, though the direct impact on near-term earnings is unclear. Fortune workplace ranking article
  • Negative Sentiment: CEO Michel Khalaf sold 187,425 shares for about $19.3 million, reducing his position by 19.8%. Insider sales can concern investors, although Khalaf retained 759,013 shares after the transaction. CEO share sale article

About MetLife

(Free Report)

MetLife, Inc. is a global financial services company best known for providing insurance, employee benefits and retirement-related products. Its offerings include life, dental and disability insurance, annuities, and products and services designed to help individuals and employers plan for financial protection and retirement. The company serves individuals, businesses and institutions in the United States and international markets, including countries in Latin America, Asia, Europe and the Middle East.

Featured Articles

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.